Inventor · disambiguated record
Jordan Jarjour
Also filed as: JARJOUR JORDAN
21 granted patents·20 pending applications·132 citations·filing 2014–2025
94Inventor score
Top patents by PatentIndex Score
41 records- 0194US10927367B2CBLB endonuclease variants, compositions, and methods of useBLUEBIRD BIO INC·Filed 2019·Granted Feb 23, 2021·13 cites·12 claims
- 0294US10793843B2CBLB endonuclease variants, compositions, and methods of useBLUEBIRD BIO INC·Filed 2019·Granted Oct 6, 2020·13 cites·9 claims
- 0394US10457731B2Multipartite signaling proteins and uses thereofBLUEBIRD BIO INC·Filed 2018·Granted Oct 29, 2019·19 cites·27 claims
- 0493US10428142B2Multipartite signaling proteins and uses thereofBLUEBIRD BIO INC·Filed 2015·Granted Oct 1, 2019·19 cites·4 claims
- 0592US10196444B2Multipartite signaling proteins and uses thereofBLUEBIRD BIO INC·Filed 2014·Granted Feb 5, 2019·22 cites·27 claims
- 0689US11530265B2Multipartite signaling proteins and uses thereof2SEVENTY BIO INC·Filed 2019·Granted Dec 20, 2022·3 cites·26 claims
- 0789US11365226B2PD-1 homing endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2017·Granted Jun 21, 2022·5 cites·13 claims
- 0888US11779654B2PCSK9 endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2018·Granted Oct 10, 2023·5 cites·15 claims
- 0988US10006052B2Laglidadg homing endonuclease cleaving the C-C chemokine receptor type-5 (CCR5) gene and uses thereofCELLECTIS·Filed 2014·Granted Jun 26, 2018·17 cites·14 claims
- 1085US11732255B2CBLB endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2021·Granted Aug 22, 2023·1 cites·15 claims
- 1182US12391734B2PD-1 homing endonuclease variants, compositions, and methods of useREGENERON PHARMA·Filed 2024·Granted Aug 19, 2025·0 cites·27 claims
- 1282US10000746B2LAGLIDADG homing endonuclease cleaving the T cell receptor alpha gene and uses thereofCELLECTICS·Filed 2014·Granted Jun 19, 2018·14 cites·21 claims
- 1380US2023287111A1Multipartite signaling proteins and uses thereof2SEVENTY BIO INC·Filed 2022·Application pending·0 cites
- 1477US12291560B2Dimerizing agent regulated immunoreceptor complexesREGENERON PHARMA·Filed 2019·Granted May 6, 2025·1 cites·10 claims
- 1576US2024189454A1Pcsk9 endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2023·Application pending·0 cites
- 1675US12264343B2TCRa homing endonuclease variantsREGENERON PHARMA·Filed 2023·Granted Apr 1, 2025·0 cites·19 claims
- 1774US11912746B2PD-1 homing endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2022·Granted Feb 27, 2024·0 cites·16 claims
- 1871US2025327049A1Cblb endonuclease variants, compositions, and methods of useREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1970US12297465B2CBLB endonuclease variants, compositions, and methods of useREGENERON PHARMA·Filed 2021·Granted May 13, 2025·0 cites·7 claims
- 2070US2025262323A1Pcsk9 endonuclease variants, compositions, and methods of useNOVO NORDISK AS·Filed 2025·Application pending·0 cites
- 2170US2025179469A1Cblb endonuclease variants, compositions, and methods of useREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 2269US2025312451A1Multipartite receptor and signaling complexesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2369US2025242024A1Multipartite receptor and signaling complexesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2468US12227740B2CBLB endonuclease variants, compositions, and methods of useREGENERON PHARMA·Filed 2018·Granted Feb 18, 2025·0 cites·11 claims
- 2567US2025368973A1Homing endonuclease variantsNOVO NORDISK AS·Filed 2025·Application pending·0 cites
- 2665US2020071399A1Multipartite signaling proteins and uses thereofBLUEBIRD BIO INC·Filed 2019·Application pending·0 cites
- 2761US12421315B2CLL-1 targeted immunotherapiesREGENERON PHARMA·Filed 2020·Granted Sep 23, 2025·0 cites·20 claims
- 2860US11591582B2TCRα homing endonuclease variants2SEVENTY BIO INC·Filed 2017·Granted Feb 28, 2023·0 cites·15 claims
- 2960US2024342215A1Engineered t cell receptors fused to binding domains from antibodiesREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 3056US12404500B2Homing endonuclease variantsNOVO NORDISK AS·Filed 2019·Granted Sep 2, 2025·0 cites·20 claims
- 3156US2024336904A1Compositions and methods for site-directed mutagenesis2SEVENTY BIO INC·Filed 2021·Application pending·0 cites
- 3250US2022315638A1Cd123 targeted immunotherapies2SEVENTY BIO INC·Filed 2020·Application pending·0 cites
- 3350US2024025963A1Dimerizing agent regulated immunoreceptor complexes2SEVENTY BIO INC·Filed 2019·Application pending·0 cites
- 3449US2023031838A1Dimerizing agent regulated immunoreceptor complexes2SEVENTY BIO INC·Filed 2020·Application pending·0 cites
- 3546US2021236546A1Nkg2d daric receptorsBLUEBIRD BIO INC·Filed 2018·Application pending·0 cites
- 3646US2021002621A1Ctla4 homing endonuclease variants, compositions, and methods of useBLUEBIRD BIO INC·Filed 2018·Application pending·0 cites
- 3743US11530395B2TGFBetaR2 endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2017·Granted Dec 20, 2022·0 cites·19 claims
- 3842US2019309274A1Il-10 receptor alpha homing endonuclease variants, compositions, and methods of useBLUEBIRD BIO INC·Filed 2017·Application pending·0 cites
- 3940US2019241910A1Genome edited immune effector cellsBLUEBIRD BIO INC·Filed 2017·Application pending·0 cites
- 4039US2019262398A1Tim3 homing endonuclease variants, compositions, and methods of useBLUEBIRD BIO INC·Filed 2017·Application pending·0 cites
- 4137US2019184035A1Bcl11a homing endonuclease variants, compositions, and methods of useBLUEBIRD BIO INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jordan Jarjour files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →